| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Physiology, UCLA, Los Angeles, CA, USA; Medicine/Cardiology, UCLA, Los Angeles, CA, USA
2 Medicine/Cardiology, UCLA, Los Angeles, CA, USA; Department of Physiology, UCLA, Los Angeles, CA, USA
3 Medicine/Cardiology, UCLA, Los Angeles, CA, USA
4 Department of Physiology, UCLA, Los Angeles, CA, USA
5 Medicine/Anesthesiology, UCLA, Los Angeles, CA, USA
* To whom correspondence should be addressed. E-mail: peipeiping{at}earthlink.net.
The mitochondrial permeability transition (MPT) pore has recently been implicated as a potential mediator of myocardial ischemic injury. Nitric oxide (NO) donors induce a powerful late phase of cardioprotection against ischemia/reperfusion injury, however, the cellular mechanisms involved are poorly understood. The role of the MPT pore as a target of cardioprotective signaling pathways activated by NO has never been explored in detail. Thus, mice were administered the NO donor DETA/NO (0.1 mg/kg x 4, i.v.) 24 h prior to a 30-min coronary artery occlusion followed by 24 h of reperfusion. Infarct size was significantly reduced in DETA/NO-treated mice (30±2% in treated mice vs. 50±2% in control; p<0.05), demonstrating a powerful cardioprotection. To examine the role of the MPT pore, mice were administered atractyloside (Atr, 25 mg/kg, i.v.), which induces ANT-dependent MPT, 20 min prior to ischemia. Atr blocked the infarct-sparing effects of DETA/NO (infarct size was 58±1% of risk region vs 30±2% in DETA/NO; p<0.05) while Atr alone had no effect. Mitochondria isolated from DETA/NOtreated mice exhibited increased resistance to Ca2+-induced swelling by 20µmol/L CaCl2 or by a higher concentration of 200µmol/L, suggesting that cardioprotection involves decreased propensity for MPT. Pre-incubation of mitochondria from control hearts with 30 nmol/L of the pore inhibitor Cyclosporin-A prevented swelling by 200µmol/L CaCl2, confirming that Ca2+ induces mitochondrial swelling via MPT. In accordance with the effects on infarct size, administration of Atr to the mouse significantly abrogated DETA/NO-induced protection against Ca2+-induced mitochondrial swelling. These phenotypic alterations were associated with an increase in the anti-apoptotic protein, Bcl-2, suggesting that the underlying mechanisms may involve inhibition of cell death by Bcl-2. These data suggest that a critical process during NO donor-induced cardioprotection is to prevent MPT pore opening, potentially via targeting of ANT.
This article has been cited by other articles:
|
|
 |
|
  S. Javadov, M. Karmazyn, and N. Escobales Mitochondrial Permeability Transition Pore Opening as a Promising Therapeutic Target in Cardiac Diseases J. Pharmacol. Exp. Ther., September 1, 2009; 330(3): 670 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Nadtochiy, P. R.S. Baker, B. A. Freeman, and P. S. Brookes Mitochondrial nitroalkene formation and mild uncoupling in ischaemic preconditioning: implications for cardioprotection Cardiovasc Res, May 1, 2009; 82(2): 333 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. N. Dedkova and L. A. Blatter Characteristics and function of cardiac mitochondrial nitric oxide synthase J. Physiol., February 15, 2009; 587(4): 851 - 872. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ananthakrishnan, M. Kaneko, Y. C. Hwang, N. Quadri, T. Gomez, Q. Li, C. Caspersen, and R. Ramasamy Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore Am J Physiol Heart Circ Physiol, February 1, 2009; 296(2): H333 - H341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wang, N. Oka, M. Tropak, J. Callahan, J. Lee, G. Wilson, A. Redington, and C. A. Caldarone Remote ischemic preconditioning elaborates a transferable blood-borne effector that protects mitochondrial structure and function and preserves myocardial performance after neonatal cardioplegic arrest. J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 335 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. McAllister, H. Ashrafpour, N. Cahoon, N. Huang, M. A. Moses, P. C. Neligan, C. R. Forrest, J. E. Lipa, and C. Y. Pang Postconditioning for salvage of ischemic skeletal muscle from reperfusion injury: efficacy and mechanism Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R681 - R689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. T. Costa and K. D. Garlid Intramitochondrial signaling: interactions among mitoKATP, PKC{varepsilon}, ROS, and MPT Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H874 - H882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Oka, L. Wang, W. Mi, W. Zhu, O. Honjo, and C. A. Caldarone Cyclosporine A prevents apoptosis-related mitochondrial dysfunction after neonatal cardioplegic arrest J. Thorac. Cardiovasc. Surg., January 1, 2008; 135(1): 123 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Liem, H. M. Honda, J. Zhang, D. Woo, and P. Ping Past and present course of cardioprotection against ischemia- reperfusion injury J Appl Physiol, December 1, 2007; 103(6): 2129 - 2136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Townsend, S. M. Davidson, S. J. Clarke, I. Khaliulin, C. J. Carroll, T. M. Scarabelli, R. A. Knight, A. Stephanou, D. S. Latchman, and A. P. Halestrap Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stress Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H928 - H938. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Robinet, H. Millart, F. Oszust, W. Hornebeck, and G. Bellon Binding of elastin peptides to S-Gal protects the heart against ischemia/reperfusion injury by triggering the RISK pathway FASEB J, July 1, 2007; 21(9): 1968 - 1978. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Kroemer, L. Galluzzi, and C. Brenner Mitochondrial Membrane Permeabilization in Cell Death Physiol Rev, January 1, 2007; 87(1): 99 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. West, B. G. Hill, Y.-T. Xuan, and A. Bhatnagar Protein glutathiolation by nitric oxide: an intracellular mechanism regulating redox protein modification FASEB J, August 1, 2006; 20(10): 1715 - 1717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Davidson and M. R. Duchen Effects of NO on mitochondrial function in cardiomyocytes: Pathophysiological relevance Cardiovasc Res, July 1, 2006; 71(1): 10 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Garcia-Dorado, A. Rodriguez-Sinovas, M. Ruiz-Meana, J. Inserte, L. Agullo, and A. Cabestrero The end-effectors of preconditioning protection against myocardial cell death secondary to ischemia-reperfusion Cardiovasc Res, May 1, 2006; 70(2): 274 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Guo, A. B. Stein, W.-J. Wu, X. Zhu, W. Tan, Q. Li, and R. Bolli Late preconditioning induced by NO donors, adenosine A1 receptor agonists, and {delta}1-opioid receptor agonists is mediated by iNOS Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2251 - H2257. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
